These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 24338749)
1. The impact of the EMA change in definition of "dose" on the BCS dose-solubility ratio: a review of the biowaiver monographs. Sediq A; Kubbinga M; Langguth P; Dressman J J Pharm Sci; 2014 Jan; 103(1):65-70. PubMed ID: 24338749 [TBL] [Abstract][Full Text] [Related]
2. Scientific considerations concerning the EMA change in the definition of "dose" of the BCS-based biowaiver guideline and implications for bioequivalence. Daousani C; Macheras P Int J Pharm; 2015 Jan; 478(2):606-9. PubMed ID: 25437115 [TBL] [Abstract][Full Text] [Related]
3. BCS Biowaivers: Similarities and Differences Among EMA, FDA, and WHO Requirements. Davit BM; Kanfer I; Tsang YC; Cardot JM AAPS J; 2016 May; 18(3):612-8. PubMed ID: 26943914 [TBL] [Abstract][Full Text] [Related]
4. Implementing the Biopharmaceutics Classification System in Drug Development: Reconciling Similarities, Differences, and Shared Challenges in the EMA and US-FDA-Recommended Approaches. Cardot JM; Garcia Arieta A; Paixao P; Tasevska I; Davit B AAPS J; 2016 Jul; 18(4):1039-46. PubMed ID: 27116020 [TBL] [Abstract][Full Text] [Related]
5. Solubility Determination of Active Pharmaceutical Ingredients Which Have Been Recently Added to the List of Essential Medicines in the Context of the Biopharmaceutics Classification System-Biowaiver. Plöger GF; Hofsäss MA; Dressman JB J Pharm Sci; 2018 Jun; 107(6):1478-1488. PubMed ID: 29421214 [TBL] [Abstract][Full Text] [Related]
17. Classification of torasemide based on the Biopharmaceutics Classification System and evaluation of the FDA biowaiver provision for generic products of CLASS I drugs. Khan MZ; Rausl D; Radosević S; Filić D; Danilovski A; Dumić M; Knezević Z J Pharm Pharmacol; 2006 Nov; 58(11):1475-82. PubMed ID: 17132210 [TBL] [Abstract][Full Text] [Related]
18. Biowaiver Monograph for Immediate-Release Dosage Forms: Levamisole Hydrochloride. Kambayashi A; de Meijer M; Wegman K; van Veldhuizen C; Abrahamsson B; Cristofoletti R; Langguth P; Mehta M; Parr A; Polli JE; Shah VP; Dressman J J Pharm Sci; 2023 Mar; 112(3):634-639. PubMed ID: 36563854 [TBL] [Abstract][Full Text] [Related]